Marshall Islands vs San Marino: Substance use disorder deaths
Marshall Islands
0.06 deaths
in 2021
San Marino
0.03 deaths
in 2021
Marshall Islands rank
185th
San Marino rank
186th
Substance use disorder deaths over time
- Marshall Islands
- San Marino
How they compare
Marshall Islands currently reports 0.06 deaths against 0.03 deaths in San Marino, a difference of 0.03 deaths.
That makes Marshall Islands's figure about 2.0 times San Marino's.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Marshall Islands ahead.
Marshall Islands ranks 185th and San Marino ranks 186th of 194 countries.
Marshall Islands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Marshall Islands | San Marino | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.087 deaths | 0.032 deaths | 0.055 deaths | Marshall Islands |
| 2010s | 0.067 deaths | 0.048 deaths | 0.019 deaths | Marshall Islands |
| 2020s | 0.06 deaths | 0.04 deaths | 0.02 deaths | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher substance use disorder deaths, Marshall Islands or San Marino?
- Marshall Islands, at 0.06 deaths against 0.03 deaths in San Marino as of 2021.
- What is the difference in substance use disorder deaths between Marshall Islands and San Marino?
- 0.03 deaths, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and San Marino?
- 22 years are reported by both, from 2000 to 2021.
- How do Marshall Islands and San Marino rank globally for substance use disorder deaths?
- Marshall Islands ranks 185th and San Marino ranks 186th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Substance use disorder deaths. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from drug use disorders in both sexes.